Prescribing at the interface between primary and secondary care in the UK: Towards joint formularies?

PharmacoEconomics

Volumn 15, Issue 5, 1999, Pages 435-443

  Duerden, Martin ^a   Walley, Tom ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG FORMULARY; FINANCIAL MANAGEMENT; HOSPITAL; NATIONAL HEALTH SERVICE; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

EID: 0032902684     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199915050-00002     Document Type: Review

References (48)

1. Pearce M, Begg E. A review of limited lists and formularies: Are they cost effective? Pharmacoeconomics 1992; 1: 191-202
2. Voss S, Hardy N, Olds T, et al. The use of practice formularies by general practitioners in Southampton and South West Hampshire. Pharma J 1997; 258: 38-40
3. McGavock H, Wilson Davies K, McGavock S. Formulary revision: Eliciting the views of users. Br J Gen Pract 1996; 46: 419-21
4. Joshi M, Williams A, Petrie J. Hospital formularies in 1993: Where, why and how? Pharm J 1994; 253: 63-5
5. Pryce AJ, Heatlie HF, Chapman SR. Buccaling under the pressure: Influence of secondary care establishments on the prescribing of glyceryl trinitrate buccal tablets in primary care. BMJ 1996; 313: 1621-4
6. Audit Commission. A Prescription for Improvement. London: HMSO, 1994
7. Grant GB, Gregory GA, Zwanenberg TD. Development of a limited formulary for general practice. Lancet 1985; 1: 1030-2
8. Grant GB, Gregory DA, Edwards C. A Basic Formulary for General Practice: Oxford Medical Publications Practical Guides for General Practice. Oxford: Oxford University Press, 1994
9. Essex B. Practice formularies: Towards more rational prescribing [editorial]. BMJ 1989; 298: 1052
10. Green P. The general practice formulary: Its role in rational therapeutics. J R Coll Gen Pract 1985; 35: 570-2
11. Needham A, Brown M, Freeborn S. Introduction and audit of a general practice antibiotic formulary. J R Coll Gen Pract 1988; 38 (309): 166-7
12. Beardon P, Brown SV, Mowat DA, et al. Introducing a drug formulary to general practice: Effects on practice prescribing costs. J R Coll Gen Pract 1987; 37 (300): 305-7
13. Hill-Smith I. Sharing resources to create a district drug formulary: A countywide controlled trial. Br J Gen Pract 1996; 46: 271-5
14. Dowell JS, Snadden D, Dunbar JA. Changing to generic formulary: How one fundholding practice reduced prescribing costs. BMJ 1995; 310: 505-8
15. Torgerson DJ, Maynard A. Fundholding and prescribing: Prescribing practice may have been inefficient [letter]. BMJ 1995; 311: 128
16. Royal College of General Practitioners. Resource Pack: How to Produce a Practice Formulary. London: Royal College of General Practitioners, 1989
17. Onion C, Dutton C, Walley T, et al. Local clinical guidelines: Description and evaluation of a participative method for their development and implementation. Fam Pratt 1996; 13: 28-34
18. Wilkie P, Sibbald B, Raftery J, et al. Prescribing at the hospital-general practice interface. I: Hospital outpatient dispensing policies in England. BMJ 1992; 304 (6818): 29-31
19. Sibbald B, Wilkie P, Raftery J, et al. Prescribing at the hospital general practice interface. II: Impact of hospital outpatient dispensing policies in England on general practitioners and hospital consultants. BMJ 1992; 304: 31-4
20. Crump BJ, Panton R, Drummond MF, et al. Transferring the costs of expensive treatments from secondary to primary care. BMJ 1995; 310: 509-12
21. National Health Service Management Executive. Responsibility for Prescribing between Hospitals and GPs. London: National Health Service Management Executive, 1991. Report no.: EL (91)127
22. Hampson JP, Roberts RI, Morgan DA. Shared care: A review of the literature. Fam Pract 1996; 13: 264-79
23. Evans D. A stakeholder analysis of developments at the primary and secondary care interface. Br J Gen Pract 1996; 46: 675-7
24. Garvey G, Jappy B, Stewart D, et al. Grampian Health Board's joint drug formulary. BMJ 1990; 301: 851-2
25. Grampian Formulary. Aberdeen: Drug Monitoring Unit, Aberdeen Infirmary, 1995
26. Lothian Formulary. 3rd Ed. Ediburgh: Lothian Liaison Committee, Ladywell Medical Centre, 1992
27. Stewart D, Milne K, Krska J, et al. Adherence to the Grampian joint drug formulary in general practice. J Clin Pharm Ther 1996; 21: 79-82
28. NHS in Scotland Management Executive. Management of the Drug Bill. Edinburgh: The Scottish Office, 1993. Report no.: MEL(1993)12
29. General Medical Services Committee. Defining Core Services in General Practice - Reclaiming Professional Control. London: British Medical Association, 1996
30. Jones R, Rawlins M. Prescribing at the interface between hospitals and general practitioners. BMJ 1992; 304: 4-5
31. Hunter D, Fairfield G. Disease management. BMJ 1997; 315: 50-3
32. National Health Service (NHS) Executive. Commercial Approaches to the NHS Regarding Disease Management Packages. Leeds: NHS Executive, 1994. Report no.: EL (94)94
33. National Health Service (NHS) Executive. Purchasing and Prescribing. Leeds: NHS Executive, 1994. Report no.: EL(94)72
34. Wakeman A, Leach R. Joint prescribing committees: Characteristics, progress and effectiveness. Health Trends 1997; 29: 52-4
35. Young M, Colwill S, Spiby J. Transferring the costs of expensive treatments: Guidelines may clarify responsibility for prescribing [letter]. BMJ 1995; 310: 1335
36. Effective Health Care Bulletin, December 1994, No. 8: Implementing Clinical Practice Guidelines. Leeds: University of Leeds, 1994. (Now from York Centre for Reviews and Dissemination)
37. Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998; 317: 465-8
38. Grol R. Beliefs and evidence in changing clinical practice. BMJ 1997; 315: 418-21
39. Purves I, Nestor G, Williams K. Testing of PRODIGY continues. BMJ 1998; 316 (7133): 776-7
40. British National Formulary No. 36. London: BMJ Books, 1998
41. Reilly A, Taylor RJ, Webster J. General practitioners' attitudes towards the limited list. J R Coll Gen Pract 1986; 36: 151-2
42. Taylor RJ, Bond CM. Limited list: Limited effects? BMJ 1985; 291: 518-20
43. Bateman, DN. The selected list. BMJ 1993; 306: 1141-2
44. House of Commons Select Committee. Priority Setting in the NHS: The NHS Drugs Budget. Vol I: Report, Together with an Appendix and the Minutes of the Committee. London: HMSO, 1994
45. Walley T. A UK national prescribing list? Pharmacoeconomics 1995; 7: 191-202
46. Department of Health. The New NHS. London: HMSO, 1997
47. NHS Executive. A First Class Service: Quality in the New NHS. London: HMSO, 1998
48. Brooks A. Viagra is licensed in Europe but rationed in Britain. BMJ 1998; 317: 765